Financials

  • Market Capitalization 5.17 B
  • Employee 258
  • Founded 2014
  • CEO N/A
  • Website www.cogentbio.com
  • Headquarter Delaware, United States
  • FIGI BBG007DHZQR7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-16.44
Relación precio/flujo de caja
-637.59

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1247
ERAS
Erasca, Inc. - Common Stock
15.46 USD-3.56%+4.88%-3.19%+557.87%5.41 B USD
1271
PTCT
PTC Therapeutics, Inc. - Common Stock
62.92 USD-2.75%-2.49%-6.09%-3.20%5.25 B USD
1286
SRRK
Scholar Rock Holding Corporation - Common Stock
41.94 USD-0.59%-3.76%-25.78%+39.71%5.11 B USD
1303
CRSP
CRISPR Therapeutics AG - Common Shares
51.55 USD-3.45%-14.86%+0.25%-23.48%4.98 B USD

Noticias